Variant report
Variant | esv3693303 |
---|---|
Chromosome Location | chr22:21456518-21465780 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:486)
- CpG islands (count:0)
- Chromatin interactive region (count:19)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr22:21456951-21457433 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr22:21462458-21463637 | K562 | blood: | n/a | n/a |
3 | ATF1 | chr22:21459817-21459848 | K562 | blood: | n/a | n/a |
4 | ATF1 | chr22:21456948-21457439 | K562 | blood: | n/a | n/a |
5 | ATF2 | chr22:21457002-21457536 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | ATF2 | chr22:21457055-21457365 | GM12878 | blood: | n/a | n/a |
7 | ATF2 | chr22:21456997-21457475 | GM12878 | blood: | n/a | n/a |
8 | ATF2 | chr22:21456969-21457507 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | ATF3 | chr22:21456845-21457542 | K562 | blood: | n/a | n/a |
10 | ATF3 | chr22:21456887-21457665 | K562 | blood: | n/a | n/a |
11 | BACH1 | chr22:21457063-21457536 | K562 | blood: | n/a | n/a |
12 | BACH1 | chr22:21462948-21463323 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | BACH1 | chr22:21462599-21463625 | K562 | blood: | n/a | n/a |
14 | BACH1 | chr22:21457038-21457521 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | BCLAF1 | chr22:21457085-21457352 | GM12878 | blood: | n/a | n/a |
16 | BHLHE40 | chr22:21456903-21457481 | K562 | blood: | n/a | n/a |
17 | BRCA1 | chr22:21457031-21457337 | HepG2 | liver: | n/a | n/a |
18 | CBX3 | chr22:21456796-21457642 | K562 | blood: | n/a | n/a |
19 | CBX3 | chr22:21456904-21457465 | K562 | blood: | n/a | n/a |
20 | CCNT2 | chr22:21463069-21463100 | K562 | blood: | n/a | n/a |
21 | CCNT2 | chr22:21457069-21457499 | K562 | blood: | n/a | n/a |
22 | CEBPB | chr22:21460358-21460613 | HepG2 | liver: | n/a | chr22:21460477-21460488 |
23 | CEBPB | chr22:21457134-21457455 | K562 | blood: | n/a | n/a |
24 | CEBPB | chr22:21456952-21457490 | K562 | blood: | n/a | n/a |
25 | CEBPB | chr22:21460386-21460631 | K562 | blood: | n/a | chr22:21460477-21460488 |
26 | CEBPB | chr22:21457057-21457428 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | CEBPB | chr22:21457185-21457374 | HepG2 | liver: | n/a | n/a |
28 | CEBPB | chr22:21460401-21460595 | A549 | lung: | n/a | chr22:21460477-21460488 |
29 | CHD2 | chr22:21456966-21457406 | K562 | blood: | n/a | n/a |
30 | CREB1 | chr22:21457072-21457483 | A549 | lung: | n/a | n/a |
31 | CTBP2 | chr22:21456862-21457481 | H1-hESC | embryonic stem cell: | n/a | n/a |
32 | CTCF | chr22:21457200-21457350 | GM12872 | blood: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
33 | CTCF | chr22:21458380-21458530 | NHLF | lung: | n/a | n/a |
34 | CTCF | chr22:21457220-21457370 | Hela-S3 | cervix: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
35 | CTCF | chr22:21457200-21457350 | SAEC | small airway: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
36 | CTCF | chr22:21457063-21457410 | Spleen_OC | spleen: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
37 | CTCF | chr22:21457160-21457310 | BJ | skin: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
38 | CTCF | chr22:21458480-21458630 | HPAF | blood vessel: | n/a | n/a |
39 | CTCF | chr22:21457180-21457330 | GM12864 | blood: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
40 | CTCF | chr22:21457220-21457370 | HEK293 | kidney: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
41 | CTCF | chr22:21457099-21457385 | SK-N-SH_RA | brain: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
42 | CTCF | chr22:21457180-21457330 | GM12872 | blood: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
43 | CTCF | chr22:21457111-21457400 | GM13977 | blood: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
44 | CTCF | chr22:21457128-21457384 | Medullo | brain: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
45 | CTCF | chr22:21458220-21458370 | AG09309 | skin: | n/a | n/a |
46 | CTCF | chr22:21457085-21457453 | HepG2 | liver: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
47 | CTCF | chr22:21457146-21457426 | LNCaP | prostate: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
48 | CTCF | chr22:21457220-21457370 | AoAF | blood vessel: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
49 | CTCF | chr22:21457180-21457330 | HA-sp | spinal cord: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
50 | CTCF | chr22:21457180-21457330 | AG04449 | skin: | n/a | chr22:21457254-21457264 chr22:21457249-21457267 chr22:21457251-21457272 chr22:21457250-21457266 |
No data |
(count:19 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:21367571..21370293-chr22:21455185..21457274,3 | K562 | blood: | |
2 | chr22:21355602..21358079-chr22:21461383..21463245,2 | MCF-7 | breast: | |
3 | chr22:21368793..21370356-chr22:21455117..21457274,2 | K562 | blood: | |
4 | chr22:21448752..21453745-chr22:21453926..21457234,4 | MCF-7 | breast: | |
5 | chr22:21314800..21316392-chr22:21454460..21457208,2 | K562 | blood: | |
6 | chr22:21334989..21337850-chr22:21456827..21459546,2 | K562 | blood: | |
7 | chr22:21445053..21447572-chr22:21455705..21457230,2 | K562 | blood: | |
8 | chr22:21453029..21455213-chr22:21459459..21461681,2 | K562 | blood: | |
9 | chr22:21355227..21358354-chr22:21455605..21457626,3 | K562 | blood: | |
10 | chr22:21450378..21453014-chr22:21461236..21463100,2 | K562 | blood: | |
11 | chr22:21270849..21272651-chr22:21455826..21458172,2 | MCF-7 | breast: | |
12 | chr22:21382824..21385331-chr22:21454579..21456843,2 | MCF-7 | breast: | |
13 | chr22:21270165..21272988-chr22:21455197..21456764,2 | MCF-7 | breast: | |
14 | chr22:21356384..21358791-chr22:21460678..21463188,2 | K562 | blood: | |
15 | chr22:21321706..21322599-chr22:21456736..21457719,2 | K562 | blood: | |
16 | chr22:21354638..21358198-chr22:21455223..21459884,5 | MCF-7 | breast: | |
17 | chr22:21353014..21357310-chr22:21452902..21457294,6 | MCF-7 | breast: | |
18 | chr22:21451265..21452805-chr22:21457465..21459683,2 | K562 | blood: | |
19 | chr22:21348532..21350685-chr22:21453924..21456734,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
BCRP2 | TF binding region |
ENSG00000183773 | chromatin interactions |
ENSG00000099949 | chromatin interactions |
ENSG00000161149 | chromatin interactions |
ENSG00000099957 | chromatin interactions |
ENSG00000230513 | chromatin interactions |
ENSG00000099942 | chromatin interactions |
ENSG00000272829 | chromatin interactions |
ENSG00000184436 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10483105 | chr22:21456518-21456519 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs554431305 | chr22:21456522-21456523 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
3 | rs548406410 | chr22:21456531-21456532 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
4 | rs574357899 | chr22:21456561-21456562 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
5 | rs144400939 | chr22:21456568-21456569 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
6 | rs75332019 | chr22:21456656-21456657 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
7 | rs568250790 | chr22:21456660-21456661 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
8 | rs78621282 | chr22:21456673-21456674 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
9 | rs193059648 | chr22:21456760-21456761 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
10 | rs372145481 | chr22:21456780-21456781 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
11 | rs185475605 | chr22:21456790-21456791 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
12 | rs188346646 | chr22:21456853-21456854 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
13 | rs192933416 | chr22:21456902-21456903 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
14 | rs146623269 | chr22:21456975-21456976 | Bivalent Enhancer Weak transcription Enhancers | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
15 | rs117562642 | chr22:21457030-21457031 | Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Active TSS Strong transcription Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
16 | rs566420615 | chr22:21457134-21457135 | Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Active TSS Strong transcription Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
17 | rs538294264 | chr22:21457147-21457148 | Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Active TSS Strong transcription Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
18 | rs552243862 | chr22:21457150-21457151 | Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Active TSS Strong transcription Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
19 | rs568648825 | chr22:21457167-21457168 | Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Active TSS Strong transcription Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
20 | rs527613596 | chr22:21457182-21457183 | Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Weak transcription Active TSS Strong transcription Flanking Bivalent TSS/Enh | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
21 | rs547053322 | chr22:21457207-21457208 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
22 | rs184556148 | chr22:21457216-21457217 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 9 gene(s) | Overlapped CNVs | n/a |
23 | rs554316981 | chr22:21457275-21457276 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
24 | rs188240558 | chr22:21457283-21457284 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
25 | rs180720161 | chr22:21457287-21457288 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
26 | rs183569939 | chr22:21457292-21457293 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 7 gene(s) | Overlapped CNVs | n/a |
27 | rs189423621 | chr22:21457306-21457307 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
28 | rs375458418 | chr22:21457311-21457312 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
29 | rs369605042 | chr22:21457319-21457320 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
30 | rs570481279 | chr22:21457357-21457358 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
31 | rs545100332 | chr22:21457365-21457366 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
32 | rs61744393 | chr22:21457385-21457386 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer Strong transcription | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
33 | rs575772815 | chr22:21457520-21457521 | Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
34 | rs539495478 | chr22:21457542-21457543 | Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
35 | rs556294027 | chr22:21457564-21457565 | Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
36 | rs373217305 | chr22:21457591-21457592 | Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
37 | rs569782965 | chr22:21457623-21457624 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
38 | rs433457 | chr22:21457646-21457647 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
39 | rs182084859 | chr22:21457702-21457703 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
40 | rs2543395 | chr22:21457703-21457704 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
41 | rs78008352 | chr22:21457706-21457707 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
42 | rs2519456 | chr22:21457707-21457708 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
43 | rs369967627 | chr22:21457711-21457712 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 6 gene(s) | Overlapped CNVs | n/a |
44 | rs547260096 | chr22:21457728-21457729 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
45 | rs560666567 | chr22:21457794-21457795 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
46 | rs187127325 | chr22:21457797-21457798 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
47 | rs551856334 | chr22:21457805-21457806 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
48 | rs568536829 | chr22:21457832-21457833 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
49 | rs550157626 | chr22:21457854-21457855 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
50 | rs539201076 | chr22:21457877-21457878 | Weak transcription Enhancers Active TSS | Chromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Schizophrenia | 17504246 | CNVD |
Digeorge syndrome | 18033723 | CNVD |
22q11 deletion syndrome | 17034021 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
22q11 deletion syndrome | 16829213 | CNVD |
Autism | 22067053 | CNVD |
Autism | 19218893 | CNVD |
Biliary cancer | 22067053 | CNVD |
Congenital heart defect | 21390462 | CNVD |
Digeorge syndrome | 16617304 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Obsessive-compulsive disorder | 22067053 | CNVD |
Psychosis | 22067053 | CNVD |
Schizophrenia | 19415332 | CNVD |
Schizophrenia | 20587603 | CNVD |
Shprintzen syndrome | 19443537 | CNVD |
absent pulmonary valve syndrome | 16795129 | CNVD |
language delay | 22067053 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
renal disease | 17924346 | CNVD |
Schizophrenia | 20433910 | CNVD |
22q11 deletion syndrome | 17028864 | CNVD |
Schizophrenia | 16969581 | CNVD |
Non-syndromic sensorineural hearing loss | 17135275 | CNVD |
velo-cardio-facial syndrome | 17135275 | CNVD |
Digeorge syndrome | 18787571 | CNVD |
Autism | 18925931 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
22q11.2 microdeletion syndrome | 21547621 | CNVD |
Congenital heart defect | 21308838 | CNVD |
Digeorge syndrome | 16512914 | CNVD |
Digeorge syndrome | 20954168 | CNVD |
Nuchal translucency | 21837766 | CNVD |
Right aortic arch in the fetus | 17066500 | CNVD |
Shprintzen syndrome | 17117043 | CNVD |
Tetralogy of fallot | 17405110 | CNVD |
Velocardiofacial syndrome | 20140301 | CNVD |
Velocardiofacial syndrome | 16512914 | CNVD |
bone mass and metabolism | 20516202 | CNVD |
choanal atresia | 18209138 | CNVD |
extracardiac malformations | 17086578 | CNVD |
fetal heart defects | 21308838 | CNVD |
parathyroid gland dysfunction | 16793949 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
velopharyngeal insufficiency | 19620585 | CNVD |
Prader-willi syndrome | 20942916 | CNVD |
22q11 deletion syndrome | 17653112 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cat eye syndrome | 21549014 | CNVD |
Digeorge syndrome | 21549014 | CNVD |
22q11.2 microdeletion syndrome | 22051516 | CNVD |
22q11.2 microdeletion syndrome | 18483005 | CNVD |
22q11.2 microdeletion syndrome | 19565140 | CNVD |
22q11.2 microdeletion syndrome | 20396437 | CNVD |
22q11.2 microdeletion syndrome | 21390462 | CNVD |
22q11.2 microdeletion syndrome | 21573985 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 20970697 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Congenital heart defect | 21257016 | CNVD |
Developmental delay | 18414209 | CNVD |
DiGeorge-Velo cardiofacial | 19284877 | CNVD |
Epilepsy | 20970697 | CNVD |
Heart disease | 20551144 | CNVD |
Hughes'' syndrome | 16595601 | CNVD |
Mental retardation | 18414209 | CNVD |
Okamoto syndrome | 19046188 | CNVD |
Primary immunodeficiency | 22566803 | CNVD |
Schizophrenia | 20877625 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Velocardiofacial syndrome | 17556857 | CNVD |
Velocardiofacial syndrome | 20206275 | CNVD |
Velocardiofacial syndrome | 20970697 | CNVD |
delayed speech development | 21274400 | CNVD |
velo-cardio-facial syndrome | 16511839 | CNVD |
velo-cardio-facial syndrome | 21763005 | CNVD |
22q11.2 microdeletion syndrome | 18799940 | CNVD |
Digeorge syndrome | 20877625 | CNVD |
22q11.2 microdeletion syndrome | 18923514 | CNVD |
Congenital heart defect | 22185286 | CNVD |
DiGeorge-Velo cardiofacial | 16773131 | CNVD |
Digeorge syndrome | 20186050 | CNVD |
velo-cardio-facial conotruncal-face syndrome | 20186050 | CNVD |
22q11.2 microdeletion syndrome | 22116936 | CNVD |
Disorders of sex development | 22290220 | CNVD |
22q11.2 duplication syndrome | 18923514 | CNVD |
Autism | 22095694 | CNVD |
Mental retardation | 19951919 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Mental retardation | 16773131 | CNVD |
22q11.2 microdeletion syndrome | 22395003 | CNVD |
22q11.2 microdeletion syndrome | 18691436 | CNVD |
22q11.2 microdeletion syndrome | 18053182 | CNVD |
22q11.2 microdeletion syndrome | 18324686 | CNVD |
22q11.2 microdeletion syndrome | 20074913 | CNVD |
Congenital heart defect | 20802965 | CNVD |
Congenital heart defect | 21134246 | CNVD |
DiGeorge syndrome | 19040613 | CNVD |
DiGeorge-Velo cardiofacial | 18179902 | CNVD |
Digeorge syndrome | 18172682 | CNVD |
Digeorge syndrome | 22470819 | CNVD |
Digeorge syndrome | 21364285 | CNVD |
Neuroendocrine carcinoma | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20069674 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Tetralogy of fallot | 19144126 | CNVD |
Velo-cardio-facial syndrome | 21364285 | CNVD |
Velocardiofacial syndrome | 18788013 | CNVD |
cardiac malformation | 20573211 | CNVD |
cardiac malformation | 18172682 | CNVD |
velo-cardio-facial syndrome | 18636631 | CNVD |
Schizophrenia | 21822266 | CNVD |
synaptic plasticity | 21368174 | CNVD |
Schizophrenia | 18043741 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Autism | 19046189 | CNVD |
DiGeorge-Velo cardiofacial | 19047251 | CNVD |
Hypernasal speech | 21968682 | CNVD |
Mental retardation | 17339581 | CNVD |
diverse phenotype | 16760730 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 19521722 | CNVD |
Digeorge syndrome | 19521722 | CNVD |
Autism | 19955444 | CNVD |
Schizophrenia | 19955444 | CNVD |
Mental retardation | 17124404 | CNVD |
Tourette syndrome | 20069037 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Emphysema | 19352772 | CNVD |
Schizophrenia | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
DiGeorge-Velo cardiofacial | 17597781 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Schizophrenia | 18806272 | CNVD |
Schizophrenia | 18990708 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Schizophrenia | 20075378 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
22q11.2 deletion syndrome | 22563040 | CNVD |
Disease | 21346257 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Developmental delay | 21147756 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
Cancer | 20164919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Prader-willi syndrome | 20588305 | CNVD |
T-cell acute lymphoblastic leukemia | 21980252 | CNVD |
22q11.22 microdeletion syndrome | 19193630 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Schizophrenia | 20967226 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:21435600-21457000 | Weak transcription | Right Atrium | heart |
2 | chr22:21453000-21457200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr22:21453600-21457000 | Enhancers | Hela-S3 | cervix |
4 | chr22:21454400-21457400 | Enhancers | NHDF-Ad | bronchial |
5 | chr22:21454400-21457600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr22:21454400-21457600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr22:21454400-21457600 | Enhancers | NHLF | lung |
8 | chr22:21454600-21457000 | Enhancers | Osteobl | bone |
9 | chr22:21454800-21457000 | Enhancers | A549 | lung |
10 | chr22:21454800-21457200 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
11 | chr22:21454800-21457400 | Enhancers | HMEC | breast |
12 | chr22:21454800-21457600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr22:21454800-21457600 | Enhancers | HSMM | muscle |
14 | chr22:21454800-21457600 | Enhancers | NH-A | brain |
15 | chr22:21455000-21457200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr22:21455000-21457600 | Enhancers | Muscle Satellite Cultured Cells | -- |
17 | chr22:21455000-21457600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
18 | chr22:21455200-21457600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr22:21455400-21457000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
20 | chr22:21455800-21457000 | Weak transcription | Placenta | Placenta |
21 | chr22:21455800-21457200 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |
22 | chr22:21456000-21457000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
23 | chr22:21456000-21457000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
24 | chr22:21456000-21457400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
25 | chr22:21456200-21456800 | Enhancers | Fetal Thymus | thymus |
26 | chr22:21456200-21457000 | Bivalent Enhancer | K562 | blood |
27 | chr22:21456200-21457200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
28 | chr22:21456400-21457400 | Weak transcription | NHEK | skin |
29 | chr22:21456800-21457000 | Enhancers | Brain Cingulate Gyrus | brain |
30 | chr22:21456800-21457000 | Enhancers | Brain Hippocampus Middle | brain |
31 | chr22:21456800-21457000 | Enhancers | Brain Inferior Temporal Lobe | brain |
32 | chr22:21456800-21457000 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
33 | chr22:21456800-21457200 | Weak transcription | Fetal Thymus | thymus |
34 | chr22:21456800-21457600 | Enhancers | Primary T cells from cord blood | blood |
35 | chr22:21457000-21457200 | Bivalent Enhancer | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
36 | chr22:21457000-21457200 | Bivalent Enhancer | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
37 | chr22:21457000-21457200 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
38 | chr22:21457000-21457200 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
39 | chr22:21457000-21457200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
40 | chr22:21457000-21457200 | Enhancers | Brain Anterior Caudate | brain |
41 | chr22:21457000-21457200 | Enhancers | Duodenum Smooth Muscle | Duodenum |
42 | chr22:21457000-21457200 | Bivalent Enhancer | Fetal Kidney | kidney |
43 | chr22:21457000-21457200 | Enhancers | Right Ventricle | heart |
44 | chr22:21457000-21457200 | Flanking Bivalent TSS/Enh | Stomach Smooth Muscle | stomach |
45 | chr22:21457000-21457200 | Bivalent Enhancer | Thymus | Thymus |
46 | chr22:21457000-21457200 | Flanking Active TSS | A549 | lung |
47 | chr22:21457000-21457200 | Flanking Bivalent TSS/Enh | K562 | blood |
48 | chr22:21457000-21457400 | Flanking Active TSS | H9 Derived Neuron Cultured Cells | ES cell derived |
49 | chr22:21457000-21457400 | Bivalent/Poised TSS | iPS-20b Cell Line | embryonic stem cell |
50 | chr22:21457000-21457400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |